treatment strategy Included: hydroxychloroquine, naproxen, and oseltamivir for outpatient patients with Covid 19
Not Applicable
- Conditions
- COVID-19.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20201202049566N1
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Patients with Covid 19 with concurrent disease confirmation
Positive PCR test
Bilateral lung involvement
Having symptoms of the disease
Oxygen saturation level: below 90
does not participate in another trial
least basic literacy
Exclusion Criteria
Lack of cooperation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Having symptoms indicative of cough, shortness of breath, fever. Timepoint: Daily - 14 days after treatment. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method